In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment

被引:51
作者
Hern, S
Stanton, AWB
Mellor, RH
Harland, CC
Levick, JR
Mortimer, PS
机构
[1] St George Hosp, Sch Med, Dermatol Unit, London SW17 0RE, England
[2] St George Hosp, Sch Med, Dept Physiol, London SW17 0RE, England
[3] St Helier Hosp, Dept Dermatol, Carshalton SM5 1AA, Surrey, England
基金
英国惠康基金;
关键词
blood vessels; native capillaroscopy; psoriasis; pulsed dye laser;
D O I
10.1111/J.1365-2133.2005.06435.X
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Microvascular abnormalities (capillary elongation, widening and tortuosity) are a characteristic feature of psoriasis and form one of the pathological diagnostic criteria. These changes occur early in the progression of a psoriatic plaque, before there is clinical or histological evidence of epidermal hyperplasia. Treatment of psoriatic microvessels with a pulsed dye laser (PDL) has been associated with both clinical improvement and clearance of lesions. Objectives To quantify the structural vascular abnormalities in plaque skin using noninvasive techniques in vivo. Investigations were carried out before and after PDL treatment to determine the nature of laser-induced microvascular changes and the relationship between these changes and clinical improvement. Methods Plaque microvessels were visualized using native capillaroscopy. Plaques were then treated three times with the PDL at 14-day intervals. Native capillaroscopy was repeated at 2 and 6 weeks after the final laser treatment. Images were analysed using a combination of nonstereological and stereological measurements. Results Whole body disease was stable. Treated plaques showed a 48% reduction in plaque severity score (P < 0.01). Native studies showed that the PDL significantly reduced plaque microvessel density (P < 0.05), image area fraction (P < 0.01), microvessel length density (P < 0.01) and vessel image width (P < 0.01). The reduction in plaque severity score (which denoted clinical improvement) was related quantitatively to the reduction in microvessel area per unit area of plaque skin, i.e. the image area fraction (correlation coefficient = 0.772, P < 0.01). The greatest response of plaque microvessels was within 2 weeks after the final laser treatment, while the greatest reduction in plaque severity score occurred between 2 and 6 weeks after the final laser treatment, i.e. clinical improvement was preceded by microvascular improvement. Conclusions These findings indicate that there is a close correlation between the state of the superficial vasculature and the clinical status of psoriasis. The expanded superficial microvascular bed in plaque skin is a necessary component for maintaining clinical lesions and these blood vessels are thus a legitimate target for treatment.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 44 条
[1]  
Aherne WA, 1982, MORPHOMETRY, P33
[2]  
Anderson R R, 1981, Lasers Surg Med, V1, P263
[3]   SELECTIVE PHOTOTHERMOLYSIS - PRECISE MICROSURGERY BY SELECTIVE ABSORPTION OF PULSED RADIATION [J].
ANDERSON, RR ;
PARRISH, JA .
SCIENCE, 1983, 220 (4596) :524-527
[4]   RAZOXANE (ICRF-159) IN THE TREATMENT OF PSORIASIS [J].
ATHERTON, DJ ;
WELLS, RS ;
LAURENT, MR ;
WILLIAMS, YF .
BRITISH JOURNAL OF DERMATOLOGY, 1980, 102 (03) :307-317
[5]   ULTRASTRUCTURE OF CAPILLARY LOOPS IN DERMAL PAPILLAE OF PSORIASIS [J].
BRAVERMAN, IM ;
YEN, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1977, 68 (01) :53-60
[6]  
CREAMER D, 1995, AM J PATHOL, V147, P1661
[7]   Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor thymidine phosphorylase in psoriatic epidermis [J].
Creamer, D ;
Jaggar, R ;
Allen, M ;
Bicknell, R ;
Barker, J .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (06) :851-855
[8]   OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS IN PSORIASIS [J].
DETMAR, M ;
BROWN, LF ;
CLAFFEY, KP ;
YEE, KT ;
KOCHER, O ;
JACKMAN, RW ;
BERSE, B ;
DVORAK, HF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1141-1146
[9]   KERATINOCYTE-DERIVED VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IS A POTENT MITOGEN FOR DERMAL MICROVASCULAR ENDOTHELIAL-CELLS [J].
DETMAR, M ;
YEO, KT ;
NAGY, JA ;
VANDEWATER, L ;
BROWN, LF ;
BERSE, B ;
ELICKER, BM ;
LEDBETTER, S ;
DVORAK, HF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) :44-50
[10]  
Dunnill M. S., 1982, MORPHOMETRY, P1